Keros Therapeutics, Inc. earnings per share and revenue

KROS earnings per share for the last quarter are -1.14 USD whereas the estimation was -1.36 USD which accounts for 15.92% surprise. Company revenue for the same period amounts to 3.04 M USD despite the estimated figure of 49.20 k USD. Estimated earnings per share for the next quarter are -1.20 USD, and revenue is expected to reach 1.26 M USD. Also watch annual changes over time to get a bigger picture of KROS earnings per share and revenue dynamics.